Onkologia Erradioterapikoa
Espezialitatea
Instituto de Investigación Sanitaria Biocruces Bizkaia
Barakaldo, EspañaInstituto de Investigación Sanitaria Biocruces Bizkaia-ko ikertzaileekin lankidetzan egindako argitalpenak (64)
2024
-
Creatine Supplementation and Resistance Training in Patients with Breast Cancer (CaRTiC Study): Protocol for a Randomized Controlled Trial
American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 47, Núm. 4, pp. 161-168
-
Differences in Functional Capacity between Oncologic and Non-Oncologic Populations: Reference Values
Healthcare (Switzerland), Vol. 12, Núm. 3
-
Do Oncologists Recommend the “Pill” of Physical Activity in Their Practice? Answers from the Oncologist and Patients’ Perspectives
Cancers, Vol. 16, Núm. 9
-
PEACE V-Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): Acute Toxicity of a Randomized Phase 2 Trial
European urology oncology, Vol. 7, Núm. 3, pp. 462-468
-
Prospective study of HDR brachytherapy (BT), external beam radiotherapy (EBRT) and androgen deprivation therapy (ADT): 10-years experience of an MRI-guided approach
Radiotherapy and Oncology, Vol. 190
-
What is the Role of Resistance Training in Supporting Patients with Head and Neck Cancer Receiving Radiotherapy Treatment? A Systematic Review
Journal of Science in Sport and Exercise
2023
-
A multidisciplinary consensus statement on the optimal pharmacological treatment for metastatic hormone-sensitive prostate cancer
Actas Urologicas Espanolas, Vol. 47, Núm. 2, pp. 111-126
-
Abiraterone in low-volume metastatic hormone-sensitive prostate cancer. Authors’ reply
Actas Urologicas Espanolas
-
ESTRO ACROP consensus recommendation on the target volume definition for radiation therapy of macroscopic prostate cancer recurrences after radical prostatectomy
Clinical and Translational Radiation Oncology, Vol. 43
-
ESTRO ACROP guideline on prostate bed delineation for postoperative radiotherapy in prostate cancer
Clinical and Translational Radiation Oncology, Vol. 41
-
Long-term outcomes of ultra-hypofractionated 2 fractions single day HDR brachytherapy in localized prostate cancer
Radiotherapy and Oncology, Vol. 186
-
Protocol for the SEHNeCa randomised clinical trial assesing Supervised Exercise for Head and Neck Cancer patients
BMC Cancer, Vol. 23, Núm. 1
2022
-
A New Clinical Instrument for Estimating the Ambulatory Status after Irradiation for Malignant Spinal Cord Compression
Cancers, Vol. 14, Núm. 15
-
A New and Easy-to-Use Survival Score for Patients Irradiated for Metastatic Epidural Spinal Cord Compression
Practical Radiation Oncology, Vol. 12, Núm. 4, pp. 354-362
-
Evaluation of results and costs of high precision radiotherapy (VMAT) compared with conventional radiotherapy (3D) in the treatment of cancer patients with spinal cord compression of metastatic origin
Reports of Practical Oncology and Radiotherapy, Vol. 27, Núm. 4, pp. 610-614
-
Identifying patients with malignant spinal cord compression (MSCC) near end of life who can benefit from palliative radiotherapy
Radiation Oncology, Vol. 17, Núm. 1
-
Impact of a mobile application (reminder app) on acute toxicity during radiotherapy of head-and-neck cancer – results of a randomized phase III trial (RAREST-02)
BMC Cancer, Vol. 22, Núm. 1
-
Investigation on the impact of the leaf trailing effect using the Halcyon integrated platform system
Medical Physics, Vol. 49, Núm. 9, pp. 6161-6170
-
Letter to the editor referencing “Body composition changes in patients with head and neck cancer under active treatment: a scoping review”
Supportive Care in Cancer
-
Oligorecurrent nodal prostate cancer: Radiotherapy quality assurance of the randomized PEACE V-STORM phase II trial
Radiotherapy and Oncology, Vol. 172, pp. 1-9